Citigroup Maintains Neutral on Amgen, Raises Price Target to $465
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice TargetHot
Citigroup analyst Geoff Meacham maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $405 to $465.
Citigroup analyst Geoff Meacham maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $405 to $465.